Chronic bleeding secondary to an unresectable duodenal adenocarcinoma controlled with sucralfate and famotidine.
Gonzales-Rosales
F
F
Walsh
D
D
Burkons
L
L
Burkons
J
J
Horvitz
H R
HR
D000230:Adenocarcinoma / Q000150:complications*; D000368:Aged; D004379:Duodenal Neoplasms / Q000150:complications*; D015738:Famotidine / Q000627:therapeutic use*; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy*; D006635:Histamine H2 Antagonists / Q000627:therapeutic use*; D006801:Humans; D013392:Sucralfate / Q000627:therapeutic use*
D005765:Gastrointestinal Agents; D006635:Histamine H2 Antagonists; D013392:Sucralfate; D015738:Famotidine